Biblio
hiPSC-derived bone marrow milieu identifies a clinically actionable driver of niche-mediated treatment resistance in leukemia. Cell Rep Med. 2022;3(8):100717.
Increased Bone Marrow Uptake and Accumulation of Very-Late Antigen-4 Targeted Lipid Nanoparticles. Pharmaceutics. 2023;15(6).
Leukemic stem cells activate lineage inappropriate signalling pathways to promote their growth. Nat Commun. 2024;15(1):1359.
.